These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30458057)

  • 1. Reversal of Tabun Toxicity Enabled by a Triazole-Annulated Oxime Library-Reactivators of Acetylcholinesterase.
    Kovarik Z; Kalisiak J; Hrvat NM; Katalinić M; Zorbaz T; Žunec S; Green C; Radić Z; Fokin VV; Sharpless KB; Taylor P
    Chemistry; 2019 Mar; 25(16):4100-4114. PubMed ID: 30458057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Counteracting tabun inhibition by reactivation by pyridinium aldoximes that interact with active center gorge mutants of acetylcholinesterase.
    Kovarik Z; Maček Hrvat N; Kalisiak J; Katalinić M; Sit RK; Zorbaz T; Radić Z; Fokin VV; Sharpless KB; Taylor P
    Toxicol Appl Pharmacol; 2019 Jun; 372():40-46. PubMed ID: 30978400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun.
    Kassa J; Kuca K; Karasova J; Musilek K
    Mini Rev Med Chem; 2008 Oct; 8(11):1134-43. PubMed ID: 18855728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.
    Lo R; Ganguly B
    Mol Biosyst; 2014 Jul; 10(9):2368-83. PubMed ID: 24964273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations.
    Katalinić M; Šinko G; Maček Hrvat N; Zorbaz T; Bosak A; Kovarik Z
    Toxicology; 2018 Aug; 406-407():104-113. PubMed ID: 29772260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K; Jung YS
    Drug Chem Toxicol; 2008; 31(3):371-81. PubMed ID: 18622871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds.
    Worek F; Widmann R; Knopff O; Szinicz L
    Arch Toxicol; 1998 Mar; 72(4):237-43. PubMed ID: 9587020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction kinetics of oximes with native, phosphylated and aged human acetylcholinesterase.
    Radić Z; Kalisiak J; Fokin VV; Sharpless KB; Taylor P
    Chem Biol Interact; 2010 Sep; 187(1-3):163-6. PubMed ID: 20412789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxime-mediated in vitro reactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase.
    Sahu AK; Sharma R; Gupta B; Musilek K; Kuca K; Acharya J; Ghosh KK
    Toxicol Mech Methods; 2016 Jun; 26(5):319-26. PubMed ID: 27101948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
    J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of pyridinium oximes with acetylcholinesterase and their effect on organophosphate-poisoned mice.
    Kovarik Z; Calić M; Vrdoljak AL; Radić B
    J Mol Neurosci; 2006; 30(1-2):113-4. PubMed ID: 17192653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning.
    Kovarik Z; Calić M; Sinko G; Bosak A; Berend S; Vrdoljak AL; Radić B
    Chem Biol Interact; 2008 Sep; 175(1-3):173-9. PubMed ID: 18501341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
    Worek F; Aurbek N; Thiermann H
    J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxime K203: a drug candidate for the treatment of tabun intoxication.
    Gorecki L; Soukup O; Kucera T; Malinak D; Jun D; Kuca K; Musilek K; Korabecny J
    Arch Toxicol; 2019 Mar; 93(3):673-691. PubMed ID: 30564897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
    Worek F; Koller M; Thiermann H; Wille T
    Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase.
    Winter M; Wille T; Musilek K; Kuca K; Thiermann H; Worek F
    Toxicol Lett; 2016 Feb; 244():136-142. PubMed ID: 26210933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.